EP3593814
ANTIBODY FORMULATION
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
11.6.2013EP published:
21.1.2026EP application number:
19185836.4
EPO information:
European Patent Register
Max expiry date:
10.6.2033Expiry date:
10.6.2026
Title in English:
ANTIBODY FORMULATIONLanguage of the patent:
English
Timeline
Today
11.6.2013EP application
21.1.2026EP Publication
10.6.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
Cosenza, MartaAddress:
4002 Basel, CH
Name:
Stark, ChristophAddress:
4002 Basel, CH
Priority
Number:
201261658472 PDate:
12.6.2012Country:
US
Classification
Categories:
A61K 39/395, A61K 9/00, A61K 47/18, A61K 47/26, C07K 16/28, A61P 29/00, A61P 35/02